Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Parkinson’s disease and related disorders

Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease.

Tushar Kamath; Abdulraouf Abdulraouf; S J Burris; Jonah Langlieb; Vahid Gazestani; Naeem M Nadaf; Karol Balderrama; Charles Vanderburg; Evan Z Macosko

Originally published in Nature neuroscience · 2022-05-05

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

The loss of dopamine (DA) neurons within the substantia nigra pars compacta (SNpc) is a defining pathological hallmark of Parkinson's disease (PD). Nevertheless, the molecular features associated with DA neuron vulnerability have not yet been fully identified. Here, we developed a protocol to enrich and transcriptionally profile DA neurons from patients with PD and matched controls, sampling a total of 387,483 nuclei, including 22,048 DA neuron profiles. We identified ten populations and spatially localized each within the SNpc using Slide-seq. A single subtype, marked by the expression of the gene AGTR1 and spatially confined to the ventral tier of SNpc, was highly susceptible to loss in PD and showed the strongest upregulation of targets of TP53 and NR2F2, nominating molecular processes associated with degeneration. This same vulnerable population was specifically enriched for the heritable risk associated with PD, highlighting the importance of cell-intrinsic processes in determining the differential vulnerability of DA neurons to PD-associated degeneration.

Discussion

In this study we generated a molecular taxonomy of human SNpc DA neurons, spatially localized them within the SNpc and identified one DA subpopulation, SOX6_AGTR1, that is highly susceptible to neurodegeneration in PD. Importantly, across both the substantia nigra and caudate, this population was the most strongly enriched for expression of genes associated with PD by previous GWAS, suggesting that the genetic risk of PD acts preferentially in the most vulnerable neurons to influence their survival.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?